Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Precigen Inc’s stock clocked out at $1.57, up 1.29% from its previous closing price of $1.55. In other words, the price has increased by $1.29 from its previous closing price. On the day, 1.16 million shares were traded. PGEN stock price reached its highest trading level at $1.655 during the session, while it also had its lowest trading level at $1.55.
Ratios:
To gain a deeper understanding of PGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 463409056 and an Enterprise Value of 397457472. For the stock, the TTM Price-to-Sale (P/S) ratio is 118.22 while its Price-to-Book (P/B) ratio in mrq is 11.94. Its current Enterprise Value per Revenue stands at 101.263 whereas that against EBITDA is -4.407.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.94, which has changed by 0.09027779 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -2.33%, while the 200-Day Moving Average is calculated to be 27.93%.
Shares Statistics:
It appears that PGEN traded 1.68M shares on average per day over the past three months and 1174760 shares per day over the past ten days. A total of 292.87M shares are outstanding, with a floating share count of 163.01M. Insiders hold about 44.77% of the company’s shares, while institutions hold 25.48% stake in the company. Shares short for PGEN as of 1744675200 were 25355481 with a Short Ratio of 15.13, compared to 1741910400 on 22657367. Therefore, it implies a Short% of Shares Outstanding of 25355481 and a Short% of Float of 14.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
